Literature DB >> 17070093

Clinicopathological and immunohistochemical evaluation of oral squamous cell carcinoma in patients with early local recurrence.

Amanajás Francisco Carlos de Aguiar1, Luiz Paulo Kowalski, Oslei Paes de Almeida.   

Abstract

Early local recurrence is one of the main causes of treatment failure after definitive therapy of oral squamous cell carcinoma (OSCC), contributing significantly for the relative low survival rates of this neoplasia. The aim of this study was to investigate the clinical, histological and molecular factors involved in early local recurrence of OSCC, which may lead to better risk assessment in some specific cases. Twenty-seven patients with early recurrent OSCC were matched with 54 patients with the same clinical stage and tumor site but without local recurrence, in a pair-matched study design. All cases were evaluated in relation to the clinicopathological features and immunohistochemical expression of Ki-67, p53, bcl-2, FAS, Erb-B2, beta-catenin, and E-cadherin. The variables associated with ELR were alcohol consumption (p=0.019), treatment performed (p=0.041), and expression of Ki-67 (p=0.028), FAS (p=0.005) and membrane beta-catenin (p=0.026). The multivariate survival analysis (Cox regression) showed that surgery with adjuvant radiotherapy [OR=0.26 (95% CI, 0.1-0.6)] and FAS expression [OR=0.21 (95% CI, 0.1-0.5)] had a significant effect for ELR development. Radiotherapy had no significant impact on patients' overall survival. Therefore, both treatment and molecular characteristics of the tumor seem to be involved in early local recurrence.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17070093     DOI: 10.1016/j.oraloncology.2006.07.003

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  14 in total

1.  High interstitial fluid pressure promotes tumor progression through inducing lymphatic metastasis-related protein expressions in oral squamous cell carcinoma.

Authors:  T Yu; Z Wang; K Liu; Y Wu; J Fan; J Chen; C Li; G Zhu; L Li
Journal:  Clin Transl Oncol       Date:  2013-10-02       Impact factor: 3.405

Review 2.  A systematic review of p53 as a prognostic factor of survival in squamous cell carcinoma of the four main anatomical subsites of the head and neck.

Authors:  Sankalap Tandon; Catrin Tudur-Smith; Richard D Riley; Mark T Boyd; Terence M Jones
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-02       Impact factor: 4.254

3.  Impact of Clinical and Histo-Pathological Prognostic Factors on T1-2N0-1 Oral Tongue Carcinoma.

Authors:  Pichit Sittitrai; Chonticha Srivanitchapoom; Pongsak Mahanupab; Thienchai Pattarasakulchai; Rak Tananuvat; Warat Unejanum
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2012-12-02

4.  Anticancer activity of pyrithione zinc in oral cancer cells identified in small molecule screens and xenograft model: Implications for oral cancer therapy.

Authors:  Gunjan Srivastava; Ajay Matta; Guodong Fu; Raj Thani Somasundaram; Alessandro Datti; Paul G Walfish; Ranju Ralhan
Journal:  Mol Oncol       Date:  2015-05-21       Impact factor: 6.603

5.  A novel extracellular drug conjugate significantly inhibits head and neck squamous cell carcinoma.

Authors:  Larissa Sweeny; Yolanda E Hartman; Kurt R Zinn; James R Prudent; David J Marshall; Mohammed S Shekhani; Eben L Rosenthal
Journal:  Oral Oncol       Date:  2013-08-03       Impact factor: 5.337

6.  Protective role of Withaferin-A on immunoexpression of p53 and bcl-2 in 7,12-dimethylbenz(a)anthracene-induced experimental oral carcinogenesis.

Authors:  Kuppusamy Panjamurthy; Shanmugam Manoharan; Madhavan Ramados Nirmal; Lakshmanan Vellaichamy
Journal:  Invest New Drugs       Date:  2008-11-14       Impact factor: 3.850

7.  Fascin overexpression promotes neoplastic progression in oral squamous cell carcinoma.

Authors:  Hunain Alam; Amruta V Bhate; Prakash Gangadaran; Sharda S Sawant; Shimul Salot; Lalit Sehgal; Prerana P Dange; Devendra A Chaukar; Anil K D'cruz; Sadhna Kannanl; Rajiv Gude; Shubhada Kane; Sorab N Dalal; Milind M Vaidya
Journal:  BMC Cancer       Date:  2012-01-20       Impact factor: 4.430

8.  E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: a retrospective cohort study.

Authors:  Sandra Ventorin von Zeidler; Talitha de Souza Botelho; Elismauro Francisco Mendonça; Aline Carvalho Batista
Journal:  BMC Cancer       Date:  2014-12-17       Impact factor: 4.430

9.  The expression profile of microRNAs in a model of 7,12-dimethyl-benz[a]anthrance-induced oral carcinogenesis in Syrian hamster.

Authors:  Tao Yu; Xiao-yi Wang; Ren-guo Gong; An Li; Sen Yang; Yu-tang Cao; Yu-ming Wen; Chang-mei Wang; Xin-zhu Yi
Journal:  J Exp Clin Cancer Res       Date:  2009-05-13

10.  Clinical significance of altered expression of β-catenin and E-cadherin in oral dysplasia and cancer: potential link with ALCAM expression.

Authors:  Jatinder Kaur; Meenakshi Sawhney; Siddhartha DattaGupta; Nootan Kumar Shukla; Anurag Srivastava; Paul G Walfish; Ranju Ralhan
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.